P2RX7 and in situ carcinoma: Data have shown a significant decrease in the expression of the P2X7 and A2A receptors in A375 and B16F10 cells after treatment with CA, BM, and the combinations of CIS + CA and CIS + BM, compared to the negative control (Figure 7E,F).